Abstract
Pneumoconiosis is one of the most common occupational diseases in the world, and specific treatment methods of pneumoconiosis are lacking at present, so it carries great social and economic burdens. Pneumoconiosis, coronavirus disease 2019, and idiopathic pulmonary fibrosis all have similar typical pathological changes—pulmonary fibrosis. Pulmonary fibrosis is a chronic lung disease characterized by excessive deposition of the extracellular matrix and remodeling of the lung tissue structure. Clarifying the pathogenesis of pneumoconiosis plays an important guiding role in its treatment. The occurrence and development of pneumoconiosis are accompanied by epigenetic factors (e.g., DNA methylation and noncoding RNA) changes, which in turn can promote or inhibit the process of pneumoconiosis. Here, we summarize epigenetic changes and functions in the several kinds of evidence classification (epidemiological investigation, in vivo, and in vitro experiments) and main types of cells (macrophages, fibroblasts, and alveolar epithelial cells) to provide some clues for finding specific therapeutic targets for pneumoconiosis and even for pulmonary fibrosis.
Funder
National Natural Science Foundation of China
Reference144 articles.
1. Analysis on the disease burden and its impact factors of coal worker’s pneumoconiosis inpatients;Zhang L.;Journal of Peking University Health Science,2014
2. FuhaiS. Study on the epidemic law and future incidence prediction of coal worker's pneumoconiosis in Datong coal mine group and its prevention and control economic benefits 2013 Doctor.
3. Research on disease burden of pneumoconiosis patients in Chongqing city;Mengliang Y.;Modern Preventive Medicine,2011
4. Analysis on the economic loss and its impact factors based on 136 pneumoconiosis patients;Qiaoling F.;Chinese Journal of Industrial Medicine,2004
5. Epigenetic Regulation
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献